Apolipoprotein L1

Displaying 1 - 6 of 6CSV
Simeone, C. A., McNulty, M. T., Gupta, Y., Genovese, G., Sampson, M. G., Sanna-Cherchi, S., Friedman, D. J., & Pollak, M. R. (2024). The APOL1 p.N264K variant is co-inherited with the G2 kidney disease risk variant through a proximity recombination event. G3: Genes, Genomes, Genetics. https://doi.org/10.1093/g3journal/jkae290
Publication Date
Elliott, M. D., Vena, N., Marasa, M., Cocchi, E., Bheda, S., Bogyo, K., Shang, N., Zanoni, F., Verbitsky, M., Wang, C., Kolupaeva, V., Jin, G., Sofer, M., Gras Pena, R., Canetta, P. A., Bomback, A. S., Guay-Woodford, L. M., Hou, J., Gillespie, B. W., … Gharavi, A. G. (2024). Increased risk of kidney failure in patients with genetic kidney disorders. Journal of Clinical Investigation, 134(17). https://doi.org/10.1172/jci178573
Publication Date
McIntosh, T., Walsh, H., Baldwin, K., Iltis, A., Mohan, S., Sawinski, D., Goodman, M., & DuBois, J. M. (2024). Evaluating ApoL1 Genetic Testing Policy Options for Transplant Centers. Clinical Journal of the American Society of Nephrology, 19(4), 494–502. https://doi.org/10.2215/cjn.0000000000000397
Publication Date
Elliott, M. D., Marasa, M., Cocchi, E., Vena, N., Zhang, J. Y., Khan, A., Krishna Murthy, S., Bheda, S., Milo Rasouly, H., Povysil, G., Kiryluk, K., & Gharavi, A. G. (2023). Clinical and Genetic Characteristics of CKD Patients with High-Risk APOL1 Genotypes. Journal of the American Society of Nephrology, 34(5), 909–919. https://doi.org/10.1681/asn.0000000000000094
Publication Date
Khan, A., Turchin, M. C., Patki, A., Srinivasasainagendra, V., Shang, N., Nadukuru, R., Jones, A. C., Malolepsza, E., Dikilitas, O., Kullo, I. J., Schaid, D. J., Karlson, E., Ge, T., Meigs, J. B., Smoller, J. W., Lange, C., Crosslin, D. R., Jarvik, G. P., Bhatraju, P. K., … Kiryluk, K. (2022). Genome-wide polygenic score to predict chronic kidney disease across ancestries. Nature Medicine, 28(7), 1412–1420. https://doi.org/10.1038/s41591-022-01869-1
Publication Date